OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Oscar Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$32.54+0.65 (+2.04%)
Close on Oct 19, 2026
- Market cap
- $10.85B
- P/E (TTM)
- 23.2
- Dividend yield
- –
Share price
+$13.15 (+67.82%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Oscar Health, Inc. grew revenue 42.8% to $15.32B over the twelve months to Jun 30, 2026. Free cash flow was $4.38B, up 264.5% from a year earlier.
Revenue
$15.32B
+42.8% vs. a year earlier
Operating income
$629.72M
TTM Q2 2026
Free cash flow
$4.38B
+264.5% vs. a year earlier
EPS, diluted
$1.40
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $10.85B
- P/E ratio
- 23.2
- Price to sales
- 0.71
- Price to book
- 5.29
- Dividend yield
- –
- Free cash flow yield
- 40.37%
Fundamentals
- Revenue
- $15.32B
- Net income
- $550.74M
- EPS, diluted
- $1.40
- Free cash flow
- $4.38B
- Book value per share
- $6.15
- Diluted shares
- 333M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$15.32B+42.8% YoY
Operating income
$629.72M
Net income
$550.74M
EPS, diluted
$1.40
Free cash flow
$4.38B+264.5% YoY
Reported periodTrailing twelve months